Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Substance Abuse Technologies

This article was originally published in The Gray Sheet

Executive Summary

Substance Abuse Technologies: Expands "all-in-one" drug testing panel test to include a simultaneous saliva alcohol test, the firm states. Expected to reach the market "within 18 months," the five-minute test would be the first "non-invasive combination drug and alcohol test that is quantitative and qualitative," SAT maintains. The Fort Lauderdale, Florida company also announces the launch of its AlcoProof System for quantitative and qualitative on-site alcohol testing. The system incorporates the AlcoProof Screen disposable test and the AlcoProof Confirm breath collection tube, which is sent to a lab for gas chromatography confirmation testing...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel